Genetic Cancer Risk Assessment

Seminars in Oncology Nursing

Volumn 27, Issue 1, 2011, Pages 13-20

  Aiello Laws, Lisa ^a  

^a NONE   (United States)

Author keywords

Cancer risk assessment; Genetic counseling; Genetics; Genomics; Hereditary cancer risk

Indexed keywords

ANAMNESIS; ARTICLE; FOLLOW UP; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; INCIDENCE; MALE; METHODOLOGY; NEOPLASM; NURSE ATTITUDE; NURSING; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; RISK ASSESSMENT; STANDARD;

FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INCIDENCE; MALE; MEDICAL HISTORY TAKING; NEOPLASMS; NURSE'S ROLE; ONCOLOGIC NURSING; PATIENT EDUCATION AS TOPIC; RISK ASSESSMENT;

EID: 78751511580     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2010.11.003     Document Type: Article

References (24)

1. Essentials of genetic and genomic nursing: competencies, curricula guidelines, and outcome indicators 2009, Consensus Panel on Genetic/Genomic Nursing Competencies, American Nurses Association, Silver Spring, MD. Ed 2.
2. Resta R., Biesecker B.B., Bennett R.L., et al. A new definition of genetic counseling: National Society of Genetic Counselors' task force report. J Genet Couns 2006, 15:77-83.
3. Roesser K. How to perform a cancer risk assessment. Genetics and genomics in oncology nursing practice 2010, 49-78. Oncology Nursing Society, Pittsburgh, PA. K. Calzone, A. Masny, J. Jenkins (Eds.).
4. Qureshi N., Wilson B., Santaguida P., et al. Collection and use of cancer family history in primary care. Evidence report/technology assessment no. 159 (prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-02-0020). AHRQ publication no. 08-E001 October 2007, Agency for Healthcare Research and Quality, Rockville, MD.
5. Trepanier A., Ahrens M., McKinnon W., et al. Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors. J Genet Couns 2004, 13:83-114.
6. ®): components of the risk assessment process National Cancer Institute, Available at, Updated April 27, 2010. (accessed May, 27, 2010). http://www.cancer.gov/cancertopics/pdq/genetics/risk-assessment-and-counseling/HealthProfessional.
7. Rich E.C., Burke W., Heaton C.J., et al. Reconsidering the family history in primary care. J Gen Intern Med 2004, 19:273-280.
8. Bennett R.L., French K.S., Resta R.G., et al. Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic Counselors. J Genet Couns 2008, 17:424-433.
9. Chen S., Parmigiani G. Meta-analysis of BRCA1 and BRCA2 Penetrance. J Clin Oncol 2007, 25:1329-1333.
10. Satagopan J.M., Boyd J., Kauff N.D., et al. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clin Cancer Res 2002, 8:3776-3781.
11. Weitzel J.N., Lagos V.I., Cullinane C.A., et al. Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 2007, 297:2587-2595.
12. Lynch H.T., Lynch P.M. Clinical selection of candidates for mutational testing for cancer susceptibility. Oncology 2006, 20(Suppl):29-34.
13. Lindor N.M., McMaster M.L., Lindor C.J., et al. Concise handbook of familial cancer susceptibility syndromes. Ed 2. J Natl Cancer Inst Monogr 2008, 38:1-93.
14. National Comprehensive Cancer Network (NCCN): Genetic/familial high-risk assessment: breast and ovary, v.1.2009 Available at, Updated January, 2009. (accessed March 3, 2010). http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf.
15. Sweet K., Bradley T., Westman J. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002, 20:528-537.
16. National Comprehensive Cancer Network (NCCN): colorectal cancer screening, v.1.2010 Available at, Updated January, 2010. (accessed March 3, 2010). http://www.nccn.org/professionals/physician_gls/PDF/colorectal_screening.pdf.
17. Online Mendelian inheritance in man National Center for Biotechnology Information (NCBI), Available at, (accessed May 27, 2010). http://www.ncbi.nlm.nih.gov/omim.
18. GeneTests National Institutes of Health, Available at, (accessed May 27, 2010). http://www.ncbi.nlm.nih.gov/sites/GeneTests/.
19. Absolute cancer risk prediction models National Cancer Institute, Available at, (accessed May 27, 2010). http://riskfactor.cancer.gov/areas/assess/absolute.html.
20. Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003, 21:2397-2406. American Society of Clinical Oncology (ASCO).
21. Robson M., Storm C., Weitzel J., et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010, 28:893-901.
22. Daly M.B., Axilbund J.E., Buys S., et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Comp Canc Netw 2010, 8:562-594.
23. Genetic Information Nondiscrimination Act of 2008 (GINA). Vol. Public Law No. 110-233.
24. Lindor N.M., Burgart L., Leontovich O., et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043-1048.